Cargando…

Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement

BACKGROUND: The advantage of up‐front neck dissection (UFND) followed by chemoradiotherapy (CRT) for hypopharyngeal cancer (HPC) with advanced neck involvement remains controversial. We aimed to determine the indications. METHODS: The data of 41 and 14 patients with stage IVA/B (T1–T3 and ≥N2a) HPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Mitsuo P., Otsuki, Naoki, Kitano, Mutsukazu, Ishikawa, Kazuki, Tanaka, Kaoru, Kimura, Takayuki, Doi, Katsumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292839/
https://www.ncbi.nlm.nih.gov/pubmed/34549854
http://dx.doi.org/10.1002/hed.26881
_version_ 1784749472492814336
author Sato, Mitsuo P.
Otsuki, Naoki
Kitano, Mutsukazu
Ishikawa, Kazuki
Tanaka, Kaoru
Kimura, Takayuki
Doi, Katsumi
author_facet Sato, Mitsuo P.
Otsuki, Naoki
Kitano, Mutsukazu
Ishikawa, Kazuki
Tanaka, Kaoru
Kimura, Takayuki
Doi, Katsumi
author_sort Sato, Mitsuo P.
collection PubMed
description BACKGROUND: The advantage of up‐front neck dissection (UFND) followed by chemoradiotherapy (CRT) for hypopharyngeal cancer (HPC) with advanced neck involvement remains controversial. We aimed to determine the indications. METHODS: The data of 41 and 14 patients with stage IVA/B (T1–T3 and ≥N2a) HPC who underwent UFND followed by CRT and received CRT, respectively, were retrospectively analyzed and compared. RESULTS: The 5‐year overall survival (OS) and disease‐specific survival rates for the UFND and CRT groups were 61% and 52% (p = 0.1019), and 89% and 74% (p = 0.2333), respectively. Moreover, patients aged ≥70 years or those with a pulmonary disease history had a significantly poorer prognosis due to aspiration pneumonia in the UFND group. The 5‐year regional control (RC) for the UFND and CRT groups were 92% and 57%, respectively (p = 0.0001). CONCLUSIONS: UFND followed by CRT was feasible with satisfactory RC. To further improve OS, aspiration pneumonia prevention is essential.
format Online
Article
Text
id pubmed-9292839
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-92928392022-07-20 Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement Sato, Mitsuo P. Otsuki, Naoki Kitano, Mutsukazu Ishikawa, Kazuki Tanaka, Kaoru Kimura, Takayuki Doi, Katsumi Head Neck Original Articles BACKGROUND: The advantage of up‐front neck dissection (UFND) followed by chemoradiotherapy (CRT) for hypopharyngeal cancer (HPC) with advanced neck involvement remains controversial. We aimed to determine the indications. METHODS: The data of 41 and 14 patients with stage IVA/B (T1–T3 and ≥N2a) HPC who underwent UFND followed by CRT and received CRT, respectively, were retrospectively analyzed and compared. RESULTS: The 5‐year overall survival (OS) and disease‐specific survival rates for the UFND and CRT groups were 61% and 52% (p = 0.1019), and 89% and 74% (p = 0.2333), respectively. Moreover, patients aged ≥70 years or those with a pulmonary disease history had a significantly poorer prognosis due to aspiration pneumonia in the UFND group. The 5‐year regional control (RC) for the UFND and CRT groups were 92% and 57%, respectively (p = 0.0001). CONCLUSIONS: UFND followed by CRT was feasible with satisfactory RC. To further improve OS, aspiration pneumonia prevention is essential. John Wiley & Sons, Inc. 2021-09-22 2021-12 /pmc/articles/PMC9292839/ /pubmed/34549854 http://dx.doi.org/10.1002/hed.26881 Text en © 2021 The Authors. Head & Neck published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Sato, Mitsuo P.
Otsuki, Naoki
Kitano, Mutsukazu
Ishikawa, Kazuki
Tanaka, Kaoru
Kimura, Takayuki
Doi, Katsumi
Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement
title Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement
title_full Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement
title_fullStr Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement
title_full_unstemmed Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement
title_short Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement
title_sort up‐front neck dissection followed by chemoradiotherapy for t1–t3 hypopharyngeal cancer with advanced nodal involvement
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292839/
https://www.ncbi.nlm.nih.gov/pubmed/34549854
http://dx.doi.org/10.1002/hed.26881
work_keys_str_mv AT satomitsuop upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement
AT otsukinaoki upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement
AT kitanomutsukazu upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement
AT ishikawakazuki upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement
AT tanakakaoru upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement
AT kimuratakayuki upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement
AT doikatsumi upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement